Spence M W, Goldbloom A L, Burgess J K, D'entremont D, Ripley B A, Weldon K L
J Med Genet. 1977 Apr;14(2):91-9. doi: 10.1136/jmg.14.2.91.
Heterozygote detection for angiokeratoma corporis diffusum (Anderson-Fabry disease, ACD), an X-linked disorder of glycosphingolipid metabolism was examined using alpha-galactosidase activity, an alpha-galactosidase/beta-galactosidase activity ratios (alpha/beta ratio) in leucocytes, plasma, and hair follicles; For leucocytes, 22 obligate heterozygotes, 25 suspected heterozygotes, and 47 control subjects were studied, while for plasma, the groups were 17 obligate heterozygotes and 35 controls. The alpha/beta ratio in plasma and leucocytes was clearly a better discriminator between obligate heterozygotes and controls than alpha-galactosidase activity alone, but still failed to detect 3 obligates with leucocytes and 2 with plasma. Discrimination was not improved by joint use of plasma and leucocyte alpha/beta ratios, but was improved by measurement of hair-follicle alpha/beta ratios. The interdecile range of log (alpha-galactosidase/beta-galactosidase activity) in 20 hair follicles from each of 4 obligate and 7 suspected heterozygotes was clearly different from 11 control subjects. Accordingly, for rapid screening for carriers of ACD, we recommend use of leucocyte or plasma alpha/beta ratios which should detect greater than 85% of heterozygotes. When results are equivocal, and ancillary information suggests heterozygous status, the more time-consuming measurement of hair-follicle alpha/beta ratios is a useful additional test.
采用α-半乳糖苷酶活性、白细胞、血浆和毛囊中的α-半乳糖苷酶/β-半乳糖苷酶活性比值(α/β比值),对弥漫性躯体血管角质瘤(安德森-法布里病,ACD)这一X连锁鞘糖脂代谢紊乱疾病进行杂合子检测。对于白细胞,研究了22名确诊杂合子、25名疑似杂合子和47名对照受试者;对于血浆,相应的分组为17名确诊杂合子和35名对照。血浆和白细胞中的α/β比值显然比单独的α-半乳糖苷酶活性更能区分确诊杂合子和对照,但仍未能检测出3名白细胞确诊杂合子和2名血浆确诊杂合子。联合使用血浆和白细胞的α/β比值并不能提高鉴别能力,但测量毛囊的α/β比值可提高鉴别能力。4名确诊杂合子和7名疑似杂合子每人20个毛囊的log(α-半乳糖苷酶/β-半乳糖苷酶活性)的十分位数间距明显不同于11名对照受试者。因此,为了快速筛查ACD携带者,我们建议使用白细胞或血浆α/β比值,其应能检测出超过85%的杂合子。当结果不明确且辅助信息提示杂合子状态时,耗时较长的毛囊α/β比值测量是一项有用的补充检测。